Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
|Articles|January 25, 2021
SMFM’s 41st Annual Pregnancy Meeting: Part 1
Contemporary OB/GYN® will cover the Society for Maternal-Fetal Medicine (SMFM)’s 2021 Virtual Annual Meeting throughout the week.
Advertisement
We will cover a range of expert sessions, lectures, abstract presentations, and more.
Below is a glimpse of our upcoming coverage.
- Womxn’s Health Collaborative Symposium: Crucial conversations for Careers in MFM
- Inequities in Maternal Outcomes from Recognition to Reduction: Current Data on Disparities in Maternal Outcomes
- Special Topic Forum – Racism, Equity, and Respectful Care: A Primer for MFMs
- Scientific Forum: Practicing Equitable Global Health
View Part 2 of our coverage lineup here.
Advertisement
Related to this article
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Hormone therapy was associated with more frequent, longer migraines in postmenopausal women, but not with greater severity or analgesic use.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Stephanie S. Faubion, MD, on choosing between fezolinetant and elinzanetant, liver monitoring, follow-up, and open questions in menopause care.
NK receptor antagonists significantly improved sleep disturbance in menopausal women at 4, 12, and 24 weeks in a meta-analysis of RCTs.
Perimenopausal women who were more physically active had significantly lower symptom burden across all domains, a study of 1808 Flo app users found.
JoAnn V. Pinkerton, MD, MSCP, reviews 4 pooled elinzanetant analyses from OASIS presented at The Menopause Society Annual Meeting 2026, spanning late perimenopause, sleep, VMS reduction, and safety.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
Brain fog at menopause: Separating normal change from dementia
3
Neurokinin receptor antagonists improve menopausal sleep disturbance
4
JoAnn V. Pinkerton, MD, MSCP, on elinzanetant across menopause subpopulations at TMS 2026
5